MULTIPLE ENDOCRINE NEOPLASIA SYNDROME TYPE 2A

Course overview

Multiple endocrine neoplasia syndrome type 2 (MEN2; also called multiple endocrine adenomatosis, type 2 and Sipple’s syndrome), caused by mutations in the RET gene on chromosome 10, is characterized by the development of medullary thyroid carcinoma (MTC). MEN2 is autosomal dominant and is typically inherited rather than the result of spontaneous mutation. This continuing education module is designed to give the reader/learner an increased understanding of MEN2A, its clinical presentation, symptoms, and treatment for patients with this diagnosis. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.